# VenaSeal Sapheon Closure System Pivotal Study (VeClose)

> **NCT01807585** · NA · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 242 (actual)

## Conditions studied

- Great Saphenous Vein (GSV) With Venous Reflux Disease

## Interventions

- **DEVICE:** VenaSeal SCS
- **DEVICE:** ClosureFast Radiofrequency Ablation (RFA)
- **DEVICE:** Roll-in (VenaSeal SCS)

## Key facts

- **NCT ID:** NCT01807585
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-12
- **Final completion:** 2017-04-10
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2018-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807585, "VenaSeal Sapheon Closure System Pivotal Study (VeClose)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01807585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*